Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Liu

Showing results (411-420 of 420) with videos related to

Pageof 42
Sort By:
You have reached the last page of results.This site can display upto 420 results.
Nature Genetics|June 2, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Nature Cancer|January 29, 2024
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activationMeri Rogava, Tyler J Aprati, Wei-Yu Chi, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapyOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
The Journal of Clinical Investigation|November 2, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Nature|November 7, 2024
Automated real-world data integration improves cancer outcome predictionJustin Jee, Christopher Fong, Karl Pichotta, et al.
Royal Society Open Science|March 20, 2025
The reliability of replications: a study in computational reproductionsNate Breznau, Eike Mark Rinke, Alexander Wuttke, et al.
Pageof 42

Showing results (411-420 of 420) with videos related to

Sort By:
Pageof 42
You have reached the last page of results.This site can display upto 420 results.
Nature Genetics|June 2, 2019
Publisher Correction: The long tail of oncogenic drivers in prostate cancerJoshua Armenia, Stephanie A M Wankowicz, David Liu, et al.
Science Advances|November 27, 2024
Genomic heterogeneity and ploidy identify patients with intrinsic resistance to PD-1 blockade in metastatic melanomaGiuseppe Tarantino, Cora A Ricker, Annette Wang, et al.
Nature Cancer|January 29, 2024
Loss of Pip4k2c confers liver-metastatic organotropism through insulin-dependent PI3K-AKT pathway activationMeri Rogava, Tyler J Aprati, Wei-Yu Chi, et al.
Biorxiv : the Preprint Server for Biology|February 26, 2024
Disrupting CD38-driven T cell dysfunction restores sensitivity to cancer immunotherapyOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
The Journal of Clinical Investigation|September 5, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
The Journal of Clinical Investigation|November 2, 2018
Immunogenomic analyses associate immunological alterations with mismatch repair defects in prostate cancerDaniel Nava Rodrigues, Pasquale Rescigno, David Liu, et al.
Cell|November 3, 2018
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint BlockadeLivnat Jerby-Arnon, Parin Shah, Michael S Cuoco, et al.
Cell Reports. Medicine|June 27, 2025
Overcoming resistance to immunotherapy by targeting CD38 in human tumor explantsOr-Yam Revach, Angelina M Cicerchia, Ofir Shorer, et al.
Nature|November 7, 2024
Automated real-world data integration improves cancer outcome predictionJustin Jee, Christopher Fong, Karl Pichotta, et al.
Royal Society Open Science|March 20, 2025
The reliability of replications: a study in computational reproductionsNate Breznau, Eike Mark Rinke, Alexander Wuttke, et al.
Pageof 42